NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Reliever | ACETAMINOPHEN | Rite Aid Corporation | 9a647967-f0c6-466e-be70-34fd3de0a803 | 2026-02-02 | Warnings | 362O9ITL9D |
| Tussin Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN | HyVee Inc | 85252999-3463-45fe-b4a9-7a97960b41b1 | 2026-02-02 | Warnings | 362O9ITL9D |
| Metoprolol | METOPROLOL TARTRATE | Fresenius Kabi USA, LLC | ccb1a15e-c943-4042-ae46-550bdabfc96b | 2026-02-02 | Warnings, Adverse reactions | W5S57Y3A5L |
| CLUB WIPES USA SANITIZING WIPES | BENZALKONIUM CHLORIDE | Bubble Marketing LLC | a0e4b04c-2227-49d2-8ccc-c7647b07cb02 | 2026-02-02 | Warnings | 1038558 F5UM2KM3W7 |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Wal-Mart Stores Inc | 72365264-f9c4-49f0-be64-73d95817d358 | 2026-02-02 | Warnings | 362O9ITL9D |
| Acetaminophen 325mg | ACETAMINOPHEN | Marlex Pharmaceuticals Inc | 4a18168c-dd36-8280-e063-6394a90a7e10 | 2026-02-01 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Marlex Pharmaceuticals Inc | 4a183b7d-3a1e-5557-e063-6294a90a5493 | 2026-02-01 | Warnings | 362O9ITL9D |
| cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | HyVee Inc | 5110526f-51fd-401e-ba52-520674d34f37 | 2026-02-01 | Warnings | 362O9ITL9D |
| BCBGENERATION Hand Sanitizer WHITE JASMINE SCENT | ETHYL ALCOHOL | Diamond Life Cosmetics Trading FZCO | 2c904dad-b8d9-49c5-9cbf-b5916f05c2c1 | 2026-01-31 | Warnings | 3K9958V90M |
| Adrenal Support | ADRENALINUM, BERBERIS VULGARIS, ARGENTUM NITRICUM, NATRUM MURIATICUM, VANADIUM METALLICUM, OLEUM MORRHUAE, PETROLEUM | NaturalCare | cee52757-a86e-4251-b65f-954ac85f4e7e | 2026-01-30 | Warnings | 451W47IQ8X YKH834O4BH |
| Albuterol Sulate HFA | ALBUTEROL SULFATE | REMEDYREPACK INC. | 77d34a3c-ccc6-420a-ad31-a1af55f7de76 | 2026-01-30 | Warnings, Adverse reactions | NDA020983 2123076 021SEF3731 |
| Metoprolol Tartrate | METOPROLOL TARTRATE | Direct_Rx | 499ce022-12a7-e4e5-e063-6394a90a435a | 2026-01-30 | Warnings, Adverse reactions | 866511 W5S57Y3A5L |
| WISH RUBBING ALCOHOL 91% | ISOPROPYL ALCOHOL | LJ Pharma | 07cba887-a568-4b92-91ab-2e7831f24ab5 | 2026-01-30 | Warnings | M003 ND2M416302 |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Chartwell RX, LLC | 2ca17cd4-460e-4d54-8c53-a58a2b80e5cb | 2026-01-30 | Warnings, Adverse reactions | R61ZEH7I1I |
| First Aid Antiseptic | POVIDONE-IODINE | Rite Aid Corporation | 2f8abb6f-460f-47bf-811d-734126aa3f0b | 2026-01-30 | Warnings, Adverse reactions | M003 312564 85H0HZU99M |
| Advanced Hand Sanitizer | ALCOHOL | Rite Aid Corporation | f7eb3c0e-4e53-45d8-88f9-95026f5e3efb | 2026-01-30 | Warnings, Adverse reactions | 3K9958V90M |
| Advanced Hand Sanitizer | ETHYL ALCOHOL | Rite Aid Corporation | 5f474ef9-0459-4192-b31d-cbf69c7a2b9a | 2026-01-30 | Warnings, Adverse reactions | 3K9958V90M |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Rite Aid Corporation | c074bbaf-2fd7-485a-9e22-a368d8dd4701 | 2026-01-30 | Warnings, Adverse reactions | M003 ND2M416302 |
| Drs. pharmacy triple antibiotic plus lidocaine | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, LIDOCAINE OINTMENT | OL PHARMA TECH, LLC | 49a73b0f-90d9-3a4b-e063-6294a90acfb0 | 2026-01-30 | Warnings | M003 |
| Reef safe unscented SPF 50 mineral sunscreen 01 | TITANIUM DIOXIDE, ZINC OXIDE | Cosmuses Cosmetics (Ningbo) Co., Ltd. | 49a77ad4-508c-9617-e063-6394a90a5623 | 2026-01-30 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.